戊二醛
生物安全
甲醛
效价
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
病毒学
化学
2019年冠状病毒病(COVID-19)
生物
医学
病毒
色谱法
生物技术
病理
传染病(医学专业)
生物化学
疾病
作者
Veronika Pilchová,AhmedElmontaser Mergani,Sabrina Clever,Małgorzata Ciurkiewicz,K. Becker,Ingo Gerhauser,Wolfgang Baumgärtner,Asisa Volz,Maren von Köckritz‐Blickwede,Claudia Schulz
标识
DOI:10.1177/03009858231197128
摘要
The SARS-CoV-2 pandemic required the immediate need to transfer inactivated tissue from biosafety level (BSL)-3 to BSL-1 areas to enable downstream analytical methods. No validated SARS-CoV-2 inactivation protocols were available for either formaldehyde (FA)-fixed or glutaraldehyde (GA)-fixed tissues. Therefore, representative tissue from ferrets and hamsters was spiked with 2.2 × 106 tissue culture infectious dose 50% per ml (TCID50/ml) SARS-CoV-2 or were obtained from mice experimentally infected with SARS-CoV-2. SARS-CoV-2 inactivation was demonstrated with 4% FA or 5% GA at room temperature for 72 hours by a titer reduction of up to 103.8 TCID50/ml in different animal tissues with a maximum protein content of 100 µg/mg and a thickness of up to 10 mm for FA and 8 mm for GA. Our protocols can be easily adapted for validating the inactivation of other pathogens to allow for the transfer of biological samples from BSL-3 areas to BSL-1 laboratories.
科研通智能强力驱动
Strongly Powered by AbleSci AI